According to initial reports, patient received onxm-27/29 sn (b)(6) 2020.Patient deceased (b)(6) 2020.Multiple attempts at additional information have gone unmet.The manufacturing records for the onxm-27/29 sn (b)(6) were reviewed, and it was confirmed that all records were controlled, available for review, and met all specifications per the device master record.All lots passed functional testing and met release specifications.A review of the available information was performed.Onxm-27/29, sn (b)(6), was implanted on (b)(6) 2020 in the mitral position in an 87-year-old female patient.While screening for participation in a clinical trial, the investigational site indicated the patient was deceased.An obituary was found online that indicated a date of death of (b)(6) 2020 (same day as the implant).The cause of death was not noted in the obituary.Multiple attempts were made to acquire additional information from the hospital; however, no response was received.Thus, we do not have a discharge summary nor any post-surgical information.Consequently, we do not know whether the patient was ever discharged from the hospital, nor do we have any post-operative diagnosis with the result to indicate what, if any, contribution the valve had to the death of the patient.Although there is no evidence of valve involvement, the instructions for use for the on-x valve lists death as a possible complication of mechanical heart valve replacement [ifu].No further action is warranted at this time.This report is being submitted as required by federal regulations and does not constitute an admission that the device caused or contributed to the reported event.Furthermore, this report reflects the event as alleged by the complainant and does not imply that the information reported to cryolife is accurate or has been confirmed by cryolife.
|